Jon Cuthbert - Author on Grafa

Corvus Pharmaceuticals (NASDAQ:CRVS) shares skyrocketed more than 60% in early trading Tuesday after the company reported that its experimental oral therapy significantly cleared skin in patients with moderate-to-severe atopic dermatitis.

MSC Income Fund (NYSE:MAIN) signaled a strong finish to 2025, providing preliminary fourth-quarter results that point to rising asset values and double-digit returns on equity as it navigates a stabilizing interest rate environment.

Dyne Therapeutics (NASDAQ:DYN) secured a regulatory win in Asia as Japanese authorities granted orphan drug status to its lead candidate for myotonic dystrophy, providing the biotech with a clear path toward market exclusivity in the world’s third-largest pharmaceutical market.

Novavax (NASDAQ:NVAX) shares rose in early trading after the company reached an agreement to license its vaccine-boosting technology to Pfizer (NYSE;PFE), providing a fresh source of capital for the Maryland-based biotech.

KeyCorp (NYSE:KEY) reported record full-year results for 2025, capped by a fourth quarter that saw net income climb to $474 million, or $0.43 per diluted share.

Mercantile Bank (NASDAQ:MBWM) reported a robust finish to fiscal year 2025, characterized by double-digit profit growth and the strategic expansion of its footprint across Michigan.

Piper Sandler (NYSE:PIPR) has completed its acquisition of MENA Growth Partners (MGP), an Abu Dhabi-based merchant bank, marking the Minneapolis-based firm’s formal entry into the Gulf Cooperation Council (GCC) region.

Bitcoin’s internal market signals are improving as sell pressure fades and spot trading volumes begin to recover.

Ethereum’s record network activity may be driven by address poisoning attacks taking advantage of reduced transaction fees.

Australian Rare Earths (ASX:AR3) announced a significant metallurgical breakthrough at its Koppamurra Project.